These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 38564085

  • 1. Role of bisphosphonates in hypertrophic osteoarthropathy: a systematic review.
    Palui R, Sridharan K, Sahoo J, Suryadevara V, Kamalanathan S, Naik D, Halanaik D, Durgia H, Raj H.
    Endocrine; 2024 Aug; 85(2):883-893. PubMed ID: 38564085
    [Abstract] [Full Text] [Related]

  • 2. The use of pamidronate in hypertrophic pulmonary osteoarthropathy (HPOA).
    Speden D, Nicklason F, Francis H, Ward J.
    Aust N Z J Med; 1997 Jun; 27(3):307-10. PubMed ID: 9227815
    [Abstract] [Full Text] [Related]

  • 3. Hypertrophic pulmonary osteoarthropathy with esophageal sarcomatoid carcinoma: a case report.
    Zhao M, Du Y, Peng Q, Hui Z.
    Ann Palliat Med; 2021 May; 10(5):5862-5869. PubMed ID: 32954755
    [Abstract] [Full Text] [Related]

  • 4. Hypertrophic osteoarthropathy masquerading as lower extremity cellulitis and response to bisphosphonates.
    Mauricio O, Francis L, Athar U, Shah C, Chaudhary M, Gajra A.
    J Thorac Oncol; 2009 Feb; 4(2):260-2. PubMed ID: 19179906
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hypertrophic osteoarthropathy with zoledronic acid: case report and review of the literature.
    Jayakar BA, Abelson AG, Yao Q.
    Semin Arthritis Rheum; 2011 Oct; 41(2):291-6. PubMed ID: 21435696
    [Abstract] [Full Text] [Related]

  • 6. Hypertrophic osteoarthropathy: a palindrome with a pathogenic connotation.
    Martinez-Lavin M, Vargas A, Rivera-Viñas M.
    Curr Opin Rheumatol; 2008 Jan; 20(1):88-91. PubMed ID: 18281863
    [Abstract] [Full Text] [Related]

  • 7. Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis.
    Garske LA, Bell SC.
    Chest; 2002 Apr; 121(4):1363-4. PubMed ID: 11948079
    [Abstract] [Full Text] [Related]

  • 8. Bisphosphonates use in Pachydermoperiostosis.
    Jagdish RK, Bhatnagar MK, Malhotra A, Aggarwal R, Shailly.
    J Assoc Physicians India; 2019 Sep; 67(9):87-90. PubMed ID: 31561698
    [Abstract] [Full Text] [Related]

  • 9. Hypertrophic osteoarthropathy effectively treated with zoledronic acid.
    King MM, Nelson DA.
    Clin Lung Cancer; 2008 May; 9(3):179-82. PubMed ID: 18621629
    [Abstract] [Full Text] [Related]

  • 10. Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma.
    Suzuma T, Sakurai T, Yoshimura G, Umemura T, Tamaki T, Yoshimasu T, Naito Y.
    Anticancer Drugs; 2001 Oct; 12(9):731-4. PubMed ID: 11593054
    [Abstract] [Full Text] [Related]

  • 11. Hypertrophic pulmonary osteoarthropathy: response to chemotherapy without documented tumour response.
    Dalgleish AG.
    Aust N Z J Med; 1983 Oct; 13(5):513-6. PubMed ID: 6580872
    [Abstract] [Full Text] [Related]

  • 12. Treatment of hypertrophic osteoarthropathy in the case of pulmonary metastasis secondary-to-nasopharyngeal carcinoma with zoledronic acid: an enlightening experience.
    Sonthalia N, Mukherjee K, Saha A, Talukdar A.
    BMJ Case Rep; 2012 Nov 11; 2012():. PubMed ID: 23148395
    [Abstract] [Full Text] [Related]

  • 13. Pachydermoperiostitis and bisphosphonates.
    Bhansali A, Singh R, Sriraam M, Bhadada S.
    J Assoc Physicians India; 2006 Apr 11; 54():340. PubMed ID: 16944626
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of resistant pain in hypertrophic pulmonary osteoarthropathy with subcutaneous octreotide.
    Johnson SA, Spiller PA, Faull CM.
    Thorax; 1997 Mar 11; 52(3):298-9. PubMed ID: 9093354
    [Abstract] [Full Text] [Related]

  • 15. Touraine-Solente-Gole' syndrome.
    Gupta M, Lehl SS, Singh R, Sachdev A.
    BMJ Case Rep; 2011 Sep 28; 2011():. PubMed ID: 22679327
    [Abstract] [Full Text] [Related]

  • 16. The effect of adrenergic blockade in hypertrophic pulmonary osteoarthropathy (HPOA).
    Reardon G, Collins AJ, Bacon PA.
    Postgrad Med J; 1976 Mar 28; 52(605):170-3. PubMed ID: 1264940
    [Abstract] [Full Text] [Related]

  • 17. Hypertrophic pulmonary osteoarthropathy: an unusual presentation.
    Kumari P, Yeung P, Medani A, Kiani AN.
    Rheumatol Adv Pract; 2018 Mar 28; 2(1):rky009. PubMed ID: 31431958
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology update: pamidronate for hypertrophic pulmonary osteoarthropathy in palliative care.
    Faust B, Parkinson A, Baumrucker SJ.
    Ther Adv Rare Dis; 2022 Mar 28; 3():26330040211070298. PubMed ID: 37180420
    [Abstract] [Full Text] [Related]

  • 19. Radiotherapy for extreme hypertrophic pulmonary osteoarthropathy associated with malignancy.
    Yeo W, Leung SF, Chan AT, Chiu KW.
    Clin Oncol (R Coll Radiol); 1996 Mar 28; 8(3):195-7. PubMed ID: 8814377
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of non-steroidal anti-inflammatory drugs among patients with primary hypertrophic osteoarthropathy: A systematic review.
    Shakya P, Pokhrel KN, Mlunde LB, Tan S, Ota E, Niizeki H.
    J Dermatol Sci; 2018 Apr 28; 90(1):21-26. PubMed ID: 29305259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.